IBIO, INC. Basic Shares Outstanding (Weighted Average)
IBIO, INC. (IBIO) reported Basic Shares Outstanding (Weighted Average) of 104.06 million shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-28
- IBIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 145.35M shares, a 910.11% increase year-over-year.
- IBIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 119.60M shares, a 1112.74% increase year-over-year.
- IBIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 99.13M shares, a 985.56% increase year-over-year.
- IBIO, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 52.98M shares, a 513.70% increase year-over-year.
- IBIO, INC. weighted average number of shares outstanding, basic for fiscal 2026 was 104.06M shares, a 891.14% increase from fiscal 2025.
- IBIO, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 10.50M shares, a 174.05% increase from fiscal 2024.
- IBIO, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 3.83M shares, a 525.98% increase from fiscal 2023.
- IBIO, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 612.00K shares, a 92.98% decline from fiscal 2022.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 145.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-28 | 132.48M shares derived: average of 2 quarters · filed 2026-08-28 | 121.36M shares derived: average of 3 quarters · filed 2026-08-28 | 104.06M shares 10-K · filed 2026-08-28 | ||||
| 2026-03-31 | 119.60M shares 10-Q · filed 2026-05-12 | 109.37M shares derived: average of 2 quarters · filed 2026-05-12 | 90.30M shares 10-Q · filed 2026-05-12 | 71.53M shares derived: average of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | 99.13M shares 10-Q · filed 2026-02-10 | 76.03M shares 10-Q · filed 2026-02-10 | 55.50M shares derived: average of 3 quarters · filed 2026-08-28 | 44.09M shares derived: average of 4 quarters · filed 2026-08-28 | ||||
| 2025-09-30 | 52.98M shares 10-Q/A · filed 2025-11-17 | 33.69M shares derived: average of 2 quarters · filed 2026-08-28 | 25.74M shares derived: average of 3 quarters · filed 2026-08-28 | 21.59M shares derived: average of 4 quarters · filed 2026-08-28 | ||||
| 2025-06-30 | 14.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-28 | 12.13M shares derived: average of 2 quarters · filed 2026-08-28 | 11.13M shares derived: average of 3 quarters · filed 2026-08-28 | 10.50M shares 10-K · filed 2026-08-28 | ||||
| 2025-03-31 | 9.86M shares 10-Q · filed 2026-05-12 | 9.50M shares derived: average of 2 quarters · filed 2026-05-12 | 9.20M shares 10-Q · filed 2026-05-12 | 9.05M shares derived: average of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | 9.13M shares 10-Q · filed 2026-02-10 | 8.88M shares 10-Q · filed 2026-02-10 | 8.78M shares derived: average of 3 quarters · filed 2026-02-10 | 7.52M shares derived: average of 4 quarters · filed 2026-02-10 | ||||
| 2024-09-30 | 8.63M shares 10-Q/A · filed 2025-11-17 | 8.61M shares derived: average of 2 quarters · filed 2025-11-17 | 6.98M shares derived: average of 3 quarters · filed 2025-11-17 | 5.70M shares derived: average of 4 quarters · filed 2025-11-17 | ||||
| 2024-06-30 | 8.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-05 | 6.15M shares derived: average of 2 quarters · filed 2025-09-05 | 4.72M shares derived: average of 3 quarters · filed 2025-09-05 | 3.83M shares 10-K · filed 2025-09-05 | ||||
| 2024-03-31 | 3.71M shares 10-Q · filed 2025-05-02 | 2.78M shares derived: average of 2 quarters · filed 2025-05-02 | 2.25M shares 10-Q · filed 2025-05-02 | 1.91M shares derived: average of 4 quarters · filed 2025-05-02 | ||||
| 2023-12-31 | 1.86M shares 10-Q · filed 2025-02-10 | 1.52M shares 10-Q · filed 2025-02-10 | 1.30M shares derived: average of 3 quarters · filed 2025-02-10 | 1.14M shares derived: average of 4 quarters · filed 2025-02-10 | ||||
| 2023-09-30 | 1.20M shares 10-Q · filed 2024-11-12 | 23.97M shares 10-Q · filed 2023-11-14 | 1.03M shares derived: average of 2 quarters · filed 2024-11-12 | 905.00K shares derived: average of 3 quarters · filed 2024-11-12 | 801.25K shares derived: average of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | 858.00K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-24 | 758.50K shares derived: average of 2 quarters · filed 2024-09-24 | 669.00K shares derived: average of 3 quarters · filed 2024-09-24 | 612.00K shares 10-K/A · filed 2024-09-24 | 12.24M shares 10-K · filed 2023-09-27 | |||
| 2023-03-31 | 659.00K shares 10-Q · filed 2024-05-13 | 13.18M shares 10-Q · filed 2023-05-15 | 574.50K shares derived: average of 2 quarters · filed 2024-05-13 | 530.00K shares 10-Q · filed 2024-05-13 | 10.59M shares 10-Q · filed 2023-05-15 | 4.68M shares derived: average of 4 quarters · filed 2024-05-13 | ||
| 2022-12-31 | 490.00K shares 10-Q · filed 2024-02-09 | 9.81M shares 10-Q · filed 2023-02-14 | 466.00K shares 10-Q · filed 2024-02-09 | 9.32M shares 10-Q · filed 2023-02-14 | 6.02M shares derived: average of 3 quarters · filed 2024-02-09 | 6.69M shares derived: average of 4 quarters · filed 2024-02-09 | ||
| 2022-09-30 | 8.84M shares 10-Q · filed 2023-11-14 | 8.78M shares derived: average of 2 quarters · filed 2023-11-14 | 8.76M shares derived: average of 3 quarters · filed 2023-11-14 | 8.75M shares derived: average of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | 8.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-27 | 8.72M shares derived: average of 2 quarters · filed 2023-09-27 | 8.72M shares derived: average of 3 quarters · filed 2023-09-27 | 8.72M shares 10-K · filed 2023-09-27 | ||||
| 2022-03-31 | 8.72M shares 10-Q · filed 2023-05-15 | 218.10M shares 10-Q · filed 2022-05-12 | 8.72M shares derived: average of 2 quarters · filed 2023-05-19 | 8.72M shares 10-Q · filed 2023-05-15 | 217.99M shares 10-Q · filed 2022-05-12 | -127.01M shares derived: average of 4 quarters · filed 2023-05-19 | ||
| 2021-12-31 | 8.71M shares 10-Q/A · filed 2023-05-19 | 8.71M shares 10-Q/A · filed 2023-05-19 | -172.25M shares derived: average of 3 quarters · filed 2023-05-19 | -75.30M shares derived: average of 4 quarters · filed 2023-05-19 | ||||
| 2021-09-30 | 8.71M shares 10-Q · filed 2022-11-14 | -262.73M shares derived: average of 2 quarters · filed 2022-11-14 | -103.31M shares derived: average of 3 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | -534.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-11 | -159.32M shares derived: average of 2 quarters · filed 2022-10-11 | 7.83M shares 10-K · filed 2022-10-11 | |||||
| 2021-03-31 | 215.54M shares 10-Q · filed 2022-05-12 | 188.49M shares 10-Q · filed 2022-05-12 | ||||||
| 2014-12-31 | 70.96M shares 10-Q · filed 2015-02-24 | 68.41M shares 10-Q · filed 2015-02-24 | ||||||
| 2014-09-30 | 65.86M shares 10-Q · filed 2014-11-14 | |||||||
| 2013-12-31 | 63.98M shares 10-Q · filed 2015-02-24 | 60.34M shares 10-Q · filed 2015-02-24 | ||||||
| 2013-09-30 | 56.69M shares 10-Q · filed 2014-11-14 | |||||||
| 2012-09-30 | 47.77M shares 10-Q · filed 2013-11-14 | 47.77M shares 10-Q · filed 2012-11-14 | ||||||
| 2011-09-30 | 32.38M shares 10-Q · filed 2012-11-14 | |||||||
| 2010-09-30 | 28.27M shares 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |